Objective to evaluate the efficacy and safety of catheter ablation for atrial fibrillation(AF) in cases with rheumatic valvular heart disease.
目的：评价风湿性瓣膜病合并心房颤动（房颤）经导管射频消融的安全性和疗效。
Objective to inquire into the clinical characteristics of systemic circulation arterial embolism complicated by rheumatic valvular heart disease.
目的探讨风湿性心瓣膜病并发体循环动脉栓塞的临床特征。
Objective: to study the distribution of coronary artery lesion and identify predictors of coronary heart disease (CHD) in patients with rheumatic valvular heart disease.
目的：研究风湿性瓣膜病患者冠状动脉心脏病(CHD)的冠状动脉病变分布及CHD预测指标。
Conclusion CP was shown to improve cardiac function in patients with congestive heart failure by rheumatic valvular disease, even in the presence of a conventional CHF pharmacologic therapy.
结论常规纠正心衰治疗基础上加用磷酸肌酸，能有效促进风湿性心瓣膜病心表患者心功能恢复，缩短术前心功能调整时间。
Conclusion CP was shown to improve cardiac function in patients with congestive heart failure by rheumatic valvular disease, even in the presence of a conventional CHF pharmacologic therapy.
结论常规纠正心衰治疗基础上加用磷酸肌酸，能有效促进风湿性心瓣膜病心表患者心功能恢复，缩短术前心功能调整时间。
应用推荐